Novartis: The Market Is Wrong About This Pharma Stock - Seekingalpha.com

As if this wasn't enough, there was also recently unfavorable safety-related news about two other Novartis drugs, Tekturna and Elinogrel. Tekturna, a hypertension medication that generates $557 million of annual revenue, has been linked with stroke and ...

Snack bars contain stealth fiber, which causes gas - Houston Chronicle

A "fart chart" can help you identify your food triggers. Q: Do you know anything about a new blood pressure drug called Tekturna? Three months after my doctor prescribed this pill, I developed the most horrendous deep cough. I thought it was whooping cough.

FDA's MedWatch Safety Alerts: April 2012 - TMCnet

Amturnide (aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide) *Tekturna (aliskiren hemifumarate) *Tekturna HCT (aliskiren hemifumarate and hydrochlorothiazide) *Tekamlo (aliskiren hemifumarate and amlodipine besylate ...

Anti-cancer foods might help woman awaiting chemotherapy - Tri-State Neighbour

I put it in kitchen drawers and behind appliances.” Q:Do you know anything about a new blood pressure drug called Tekturna? Three months after my doctor prescribed this pill, I developed the most horrendous deep cough. I thought it was whooping cough.

A New Drug in the Horizon to Increase HDL Good Cholesterol levels - PR-USA.net

They also carry hypertension drugs like Cozaar (losartan), Hyzaar (losartan/HCTZ), Avapro (irbesartan) Tekturna (aliskiren), CardizemCD (diltiazemCD), Cardene (nicardipine) and Procardia (nifedipine). She continued on the benefits BMD offers to customers ...

Canada Pharmacies Alert to Dual Efficacy Prospects of HBP Drugs in Treating PTSD - PR-USA.net

The wide range of hypertension drugs include Cozaar (losartan), Hyzaar (losartan/HCTZ), Avapro (irbesartan), InnopranXL (propranolol hydrochloride), Tekturna (aliskiren), Exforge (amlodipine/valsartan), Altace (amipril) and Zestril (lisinopril).

One Agent Better for RAS Blockade - MedPage Today

Shah said that the risk-benefit ratio argues against using two RAS blockers, which include ACE inhibitors, angiotensin receptor blockers (ARBs), and the direct renin inhibitor aliskiren (Tekturna). And even in patients with heart failure who ...